<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#Cover" roleURI="http://shuttlepharma.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#BalanceSheets" roleURI="http://shuttlepharma.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#BalanceSheetsParenthetical" roleURI="http://shuttlepharma.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StatementsOfOperations" roleURI="http://shuttlepharma.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StatementsOfChangesInStockholdersEquity" roleURI="http://shuttlepharma.com/role/StatementsOfChangesInStockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StatementsOfChangesInStockholdersEquityParenthetical" roleURI="http://shuttlepharma.com/role/StatementsOfChangesInStockholdersEquityParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StatementsOfCashFlows" roleURI="http://shuttlepharma.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#OrganizationAndLiquidity" roleURI="http://shuttlepharma.com/role/OrganizationAndLiquidity" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#Leases" roleURI="http://shuttlepharma.com/role/Leases" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#NotesPayable-relatedParty" roleURI="http://shuttlepharma.com/role/NotesPayable-relatedParty" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ConvertibleNotesAndLoanAgreement" roleURI="http://shuttlepharma.com/role/ConvertibleNotesAndLoanAgreement" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#Molecule.aiAssetAcquisition" roleURI="http://shuttlepharma.com/role/Molecule.aiAssetAcquisition" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#UnitedDogecoinMergerAgreement" roleURI="http://shuttlepharma.com/role/UnitedDogecoinMergerAgreement" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StockholdersEquity" roleURI="http://shuttlepharma.com/role/StockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#DerivativeLiabilities" roleURI="http://shuttlepharma.com/role/DerivativeLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#CommitmentsAndContingencies" roleURI="http://shuttlepharma.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#BusinessSegmentInformation" roleURI="http://shuttlepharma.com/role/BusinessSegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#SubsequentEvents" roleURI="http://shuttlepharma.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#LeasesTables" roleURI="http://shuttlepharma.com/role/LeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ConvertibleNotesAndLoanAgreementTables" roleURI="http://shuttlepharma.com/role/ConvertibleNotesAndLoanAgreementTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#Molecule.aiAssetAcquisitionTables" roleURI="http://shuttlepharma.com/role/Molecule.aiAssetAcquisitionTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#UnitedDogecoinMergerAgreementTables" roleURI="http://shuttlepharma.com/role/UnitedDogecoinMergerAgreementTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StockholdersEquityTables" roleURI="http://shuttlepharma.com/role/StockholdersEquityTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#DerivativeLiabilitiesTables" roleURI="http://shuttlepharma.com/role/DerivativeLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#OrganizationAndLiquidityDetailsNarrative" roleURI="http://shuttlepharma.com/role/OrganizationAndLiquidityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfCashAndCashEquivalentsDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfCashAndCashEquivalentsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfUsefulLivesForPropertyPlantEquipmentDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfUsefulLivesForPropertyPlantEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfRight-ofUseAssetAndLeaseInformationAboutOperatingLeaseDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfRight-ofUseAssetAndLeaseInformationAboutOperatingLeaseDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfFutureNon-cancelableMinimumLeasePaymentsUnderOperatingLeaseLiabilityDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfFutureNon-cancelableMinimumLeasePaymentsUnderOperatingLeaseLiabilityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#LeasesDetailsNarrative" roleURI="http://shuttlepharma.com/role/LeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#NotesPayable-relatedPartyDetailsNarrative" roleURI="http://shuttlepharma.com/role/NotesPayable-relatedPartyDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfFairValueMeasurementUsingSignificantUnobservableInputsDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfFairValueMeasurementUsingSignificantUnobservableInputsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ConvertibleNotesAndLoanAgreementDetailsNarrative" roleURI="http://shuttlepharma.com/role/ConvertibleNotesAndLoanAgreementDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfTotalPurchaseConsiderationDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfTotalPurchaseConsiderationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfTotalPurchaseConsiderationDetailsParenthetical" roleURI="http://shuttlepharma.com/role/ScheduleOfTotalPurchaseConsiderationDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfCarryingValueOfDevelopmentTechnologyAssetDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfCarryingValueOfDevelopmentTechnologyAssetDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#Molecule.aiAssetAcquisitionDetailsNarrative" roleURI="http://shuttlepharma.com/role/Molecule.aiAssetAcquisitionDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleBalanceOfInvestmentInUnitedDogecoinDetails" roleURI="http://shuttlepharma.com/role/ScheduleBalanceOfInvestmentInUnitedDogecoinDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#UnitedDogecoinMergerAgreementDetailsNarrative" roleURI="http://shuttlepharma.com/role/UnitedDogecoinMergerAgreementDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfWarrantsActivityDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfWarrantsActivityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfRestrictedStockUnitsRsusDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfRestrictedStockUnitsRsusDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfCompensationExpensesRsusDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfCompensationExpensesRsusDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfWeightedAverageGrantDateFairValueOfStockOptionsGrantedDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfWeightedAverageGrantDateFairValueOfStockOptionsGrantedDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfOptionActivityDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfOptionActivityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#StockholdersEquityDetailsNarrative" roleURI="http://shuttlepharma.com/role/StockholdersEquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfKeyInputsForValuationAssumptionsDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfKeyInputsForValuationAssumptionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#ScheduleOfDerivativeLiabilitiesDetails" roleURI="http://shuttlepharma.com/role/ScheduleOfDerivativeLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#DerivativeLiabilitiesDetailsNarrative" roleURI="http://shuttlepharma.com/role/DerivativeLiabilitiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://shuttlepharma.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#BusinessSegmentInformationDetailsNarrative" roleURI="http://shuttlepharma.com/role/BusinessSegmentInformationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="shph-20260630.xsd#SubsequentEventsDetailsNarrative" roleURI="http://shuttlepharma.com/role/SubsequentEventsDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_InvestmentInUnitedDogecoin" xlink:label="loc_SHPHInvestmentInUnitedDogecoin" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_SHPHInvestmentInUnitedDogecoin" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaapDeferredCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_DueToUnitedDogecoin" xlink:label="loc_SHPHDueToUnitedDogecoin" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_SHPHDueToUnitedDogecoin" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_ChangeInFairValueOfConvertibleNotes" xlink:label="loc_SHPHChangeInFairValueOfConvertibleNotes" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_SHPHChangeInFairValueOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StatementsOfChangesInStockholdersEquity" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders&apos; Equity (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StatementsOfChangesInStockholdersEquityParenthetical" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Changes in Stockholders&apos; Equity (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_FinancialAdvisorFeeSettledWithSeriesB1PreferredStockAndPrefundedWarrants" xlink:label="loc_SHPHFinancialAdvisorFeeSettledWithSeriesB1PreferredStockAndPrefundedWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SHPHFinancialAdvisorFeeSettledWithSeriesB1PreferredStockAndPrefundedWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_InterestPaymentsOnConvertibleNotesAccountedForAtFairValue" xlink:label="loc_SHPHInterestPaymentsOnConvertibleNotesAccountedForAtFairValue" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SHPHInterestPaymentsOnConvertibleNotesAccountedForAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_ChangeInFairValueOfConvertibleNotes" xlink:label="loc_SHPHChangeInFairValueOfConvertibleNotes" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SHPHChangeInFairValueOfConvertibleNotes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_IncreaseDecreaseInAccruedInterestPayableRelatedParties" xlink:label="loc_SHPHIncreaseDecreaseInAccruedInterestPayableRelatedParties" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SHPHIncreaseDecreaseInAccruedInterestPayableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireSoftware" xlink:label="loc_us-gaapPaymentsToAcquireSoftware" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_PaymentsToAcquireAssetsUnderInstallmentAgreement" xlink:label="loc_SHPHPaymentsToAcquireAssetsUnderInstallmentAgreement" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_SHPHPaymentsToAcquireAssetsUnderInstallmentAgreement" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:label="loc_us-gaapPaymentForContingentConsiderationLiabilityInvestingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:label="loc_us-gaapProceedsFromDebtNetOfIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/OrganizationAndLiquidity" xlink:title="999013 - Disclosure - Organization and Liquidity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999014 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/Leases" xlink:title="999015 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/NotesPayable-relatedParty" xlink:title="999016 - Disclosure - Notes Payable-Related Party" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ConvertibleNotesAndLoanAgreement" xlink:title="999017 - Disclosure - Convertible Notes and Loan Agreement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/Molecule.aiAssetAcquisition" xlink:title="999018 - Disclosure - Molecule.ai Asset Acquisition" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/UnitedDogecoinMergerAgreement" xlink:title="999019 - Disclosure - United Dogecoin Merger Agreement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StockholdersEquity" xlink:title="999020 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/DerivativeLiabilities" xlink:title="999021 - Disclosure - Derivative Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/CommitmentsAndContingencies" xlink:title="999022 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/BusinessSegmentInformation" xlink:title="999023 - Disclosure - Business Segment Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/SubsequentEvents" xlink:title="999024 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999025 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999026 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/LeasesTables" xlink:title="999027 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ConvertibleNotesAndLoanAgreementTables" xlink:title="999028 - Disclosure - Convertible Notes and Loan Agreement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/Molecule.aiAssetAcquisitionTables" xlink:title="999029 - Disclosure - Molecule.ai Asset Acquisition (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/UnitedDogecoinMergerAgreementTables" xlink:title="999030 - Disclosure - United Dogecoin Merger Agreement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StockholdersEquityTables" xlink:title="999031 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/DerivativeLiabilitiesTables" xlink:title="999032 - Disclosure - Derivative Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/OrganizationAndLiquidityDetailsNarrative" xlink:title="999033 - Disclosure - Organization and Liquidity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999034 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="999035 - Disclosure - Schedule of Cash and Cash Equivalents (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MoneyMarketFundsAtCarryingValue" xlink:label="loc_us-gaapMoneyMarketFundsAtCarryingValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:to="loc_us-gaapMoneyMarketFundsAtCarryingValue" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfFairValueLiabilitiesMeasuredOnRecurringBasisDetails" xlink:title="999036 - Disclosure - Schedule of Fair Value Liabilities Measured on Recurring Basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfUsefulLivesForPropertyPlantEquipmentDetails" xlink:title="999037 - Disclosure - Schedule of Useful Lives for Property Plant Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="999038 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfRight-ofUseAssetAndLeaseInformationAboutOperatingLeaseDetails" xlink:title="999039 - Disclosure - Schedule of Right-of Use Asset and Lease Information about Operating Lease (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLeaseCost" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaapVariableLeaseCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLeaseCost" xlink:to="loc_us-gaapVariableLeaseCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLeaseCost" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfFutureNon-cancelableMinimumLeasePaymentsUnderOperatingLeaseLiabilityDetails" xlink:title="999040 - Disclosure - Schedule of Future Non-cancelable Minimum Lease Payments Under Operating Lease Liability (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="shph-20260630.xsd#SHPH_LesseeOperatingLeaseLiabilityPaymentsDueYearThreeAndThereafter" xlink:label="loc_SHPHLesseeOperatingLeaseLiabilityPaymentsDueYearThreeAndThereafter" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_SHPHLesseeOperatingLeaseLiabilityPaymentsDueYearThreeAndThereafter" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/LeasesDetailsNarrative" xlink:title="999041 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/NotesPayable-relatedPartyDetailsNarrative" xlink:title="999042 - Disclosure - Notes Payable-Related Party (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfFairValueMeasurementUsingSignificantUnobservableInputsDetails" xlink:title="999043 - Disclosure - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ConvertibleNotesAndLoanAgreementDetailsNarrative" xlink:title="999044 - Disclosure - Convertible Notes and Loan Agreement (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfTotalPurchaseConsiderationDetails" xlink:title="999045 - Disclosure - Schedule of Total Purchase Consideration (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfTotalPurchaseConsiderationDetailsParenthetical" xlink:title="999046 - Disclosure - Schedule of Total Purchase Consideration (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfCarryingValueOfDevelopmentTechnologyAssetDetails" xlink:title="999047 - Disclosure - Schedule of Carrying Value of Development Technology Asset (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/Molecule.aiAssetAcquisitionDetailsNarrative" xlink:title="999048 - Disclosure - Molecule.ai Asset Acquisition (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleBalanceOfInvestmentInUnitedDogecoinDetails" xlink:title="999049 - Disclosure - Schedule balance of Investment in United Dogecoin (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/UnitedDogecoinMergerAgreementDetailsNarrative" xlink:title="999050 - Disclosure - United Dogecoin Merger Agreement (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfWarrantsActivityDetails" xlink:title="999051 - Disclosure - Schedule of Warrants Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfRestrictedStockUnitsRsusDetails" xlink:title="999052 - Disclosure - Schedule of Restricted Stock Units (RSUs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfCompensationExpensesRsusDetails" xlink:title="999053 - Disclosure - Schedule of Compensation Expenses (RSUs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfWeightedAverageGrantDateFairValueOfStockOptionsGrantedDetails" xlink:title="999054 - Disclosure - Schedule of Weighted Average Grant Date Fair Value of Stock Options Granted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfOptionActivityDetails" xlink:title="999055 - Disclosure - Schedule of Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/StockholdersEquityDetailsNarrative" xlink:title="999056 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfKeyInputsForValuationAssumptionsDetails" xlink:title="999057 - Disclosure - Schedule of Key Inputs for Valuation Assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/ScheduleOfDerivativeLiabilitiesDetails" xlink:title="999058 - Disclosure - Schedule of Derivative Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/DerivativeLiabilitiesDetailsNarrative" xlink:title="999059 - Disclosure - Derivative Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999060 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/BusinessSegmentInformationDetailsNarrative" xlink:title="999061 - Disclosure - Business Segment Information (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://shuttlepharma.com/role/SubsequentEventsDetailsNarrative" xlink:title="999062 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
